Literature DB >> 26561790

Causes of neuropathy in patients referred as "idiopathic neuropathy".

Khosro Farhad1, Rebecca Traub1, Katherine M Ruzhansky1, Thomas H Brannagan1.   

Abstract

INTRODUCTION: The etiology of neuropathy was idiopathic in 20%-30% of patients despite thorough investigation, based on results from the 1980s and 1990s. Since then, new etiologies have been recognized, and skin biopsy has been used to confirm small-fiber neuropathy.
METHODS: The authors reviewed the charts of 373 patients with idiopathic neuropathy who were referred to a neuropathy center between 2002 and 2012.
RESULTS: Among the 284 eligible patients, 93 (32.7%) remained idiopathic. The most common cause was impaired glucose metabolism (72 patients, 25.3%), including diabetes in 26 and prediabetes in 46. Other etiologies were chronic inflammatory demyelinating polyneuropathy (CIDP) in 57 (20%) and monoclonal gammopathy in 20 (7%), as well as toxic, Sjögren disease, celiac disease, other immune-mediated diseases, vitamin B12 deficiency, amyloidosis, vitamin B1 and B6 deficiency, vasculitis, hypothyroidism, hereditary, Lyme disease, and anti-sulfatide antibody.
CONCLUSIONS: The major causes of undiagnosed neuropathies were impaired glucose metabolism, CIDP, and monoclonal gammopathies. Despite thorough evaluation 32.7% remained idiopathic. Muscle Nerve 53: 856-861, 2016.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  CIDP; MGUS; diabetes; idiopathic; neuropathy; prediabetes

Mesh:

Year:  2015        PMID: 26561790     DOI: 10.1002/mus.24969

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  16 in total

Review 1.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

Review 2.  Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.

Authors:  Luis Querol; Jérôme Devaux; Ricard Rojas-Garcia; Isabel Illa
Journal:  Nat Rev Neurol       Date:  2017-07-14       Impact factor: 42.937

3.  Diagnostic value of blood tests for occult causes of initially idiopathic small-fiber polyneuropathy.

Authors:  Magdalena Lang; Roi Treister; Anne Louise Oaklander
Journal:  J Neurol       Date:  2016-10-11       Impact factor: 4.849

4.  Initial Development and Validation of a Patient-Reported Symptom Survey for Small-Fiber Polyneuropathy.

Authors:  Roi Treister; Mette Lodahl; Magdalena Lang; Shelley S Tworoger; Shlomo Sawilowsky; Anne Louise Oaklander
Journal:  J Pain       Date:  2017-01-04       Impact factor: 5.820

Review 5.  Current Diagnosis and Treatment of Painful Small Fiber Neuropathy.

Authors:  Khosro Farhad
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

6.  Gluten neuropathy: prevalence of neuropathic pain and the role of gluten-free diet.

Authors:  Panagiotis Zis; Ptolemaios Georgios Sarrigiannis; Dasappaiah Ganesh Rao; Marios Hadjivassiliou
Journal:  J Neurol       Date:  2018-07-21       Impact factor: 4.849

7.  RFC1 expansions are a common cause of idiopathic sensory neuropathy.

Authors:  Riccardo Currò; Alessandro Salvalaggio; Stefano Tozza; Chiara Gemelli; Natalia Dominik; Valentina Galassi Deforie; Francesca Magrinelli; Francesca Castellani; Elisa Vegezzi; Pietro Businaro; Ilaria Callegari; Anna Pichiecchio; Giuseppe Cosentino; Enrico Alfonsi; Enrico Marchioni; Silvia Colnaghi; Simone Gana; Enza Maria Valente; Cristina Tassorelli; Stephanie Efthymiou; Stefano Facchini; Aisling Carr; Matilde Laura; Alexander M Rossor; Hadi Manji; Michael P Lunn; Elena Pegoraro; Lucio Santoro; Marina Grandis; Emilia Bellone; Nicholas J Beauchamp; Marios Hadjivassiliou; Diego Kaski; Adolfo M Bronstein; Henry Houlden; Mary M Reilly; Paola Mandich; Angelo Schenone; Fiore Manganelli; Chiara Briani; Andrea Cortese
Journal:  Brain       Date:  2021-06-22       Impact factor: 13.501

8.  Metabolic Syndrome, Neurotoxic 1-Deoxysphingolipids and Nervous Tissue Inflammation in Chronic Idiopathic Axonal Polyneuropathy (CIAP).

Authors:  Larissa Hube; Maike F Dohrn; Gergely Karsai; Sarah Hirshman; Philip Van Damme; Jörg B Schulz; Joachim Weis; Thorsten Hornemann; Kristl G Claeys
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

9.  IVIg for apparently autoimmune small-fiber polyneuropathy: first analysis of efficacy and safety.

Authors:  Xiaolei Liu; Roi Treister; Magdalena Lang; Anne Louise Oaklander
Journal:  Ther Adv Neurol Disord       Date:  2018-01-08       Impact factor: 6.570

Review 10.  Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria.

Authors:  Roy Freeman; Jennifer S Gewandter; Catharina G Faber; Christopher Gibbons; Simon Haroutounian; Giuseppe Lauria; Todd Levine; Rayaz A Malik; J Robinson Singleton; A Gordon Smith; Josh Bell; Robert H Dworkin; Eva Feldman; David N Herrmann; Ahmet Hoke; Noah Kolb; Heikki Mansikka; Anne Louise Oaklander; Amanda Peltier; Michael Polydefkis; Elissa Ritt; James W Russell; Stephen Sainati; Deborah Steiner; Roi Treister; Nurcan Üçeyler
Journal:  Neurology       Date:  2020-10-14       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.